Corbus Pharmaceuticals (NASDAQ: CRBP)
Corbus Pharmaceuticals Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Corbus Pharmaceuticals Company Info
Corbus Pharmaceuticals Holdings, Inc. is a phase 3 clinical-stage pharmaceutical company, which focuses on the development and commercialization of novel therapeutics to treat rare, chronic, and serious inflammatory and fibrotic diseases. Its products include candidate, Lenabasum, is a novel, synthetic oral endocannabinoid-mimetic drug designed to resolve chronic inflammation and fibrotic processes. Lenabasum is currently being evaluated in systemic sclerosis, cystic fibrosis, dermatomyositis, and systemic lupus erythematosus. The company was founded in April 2009 and is headquartered in Norwood, MA.
News & Analysis
This Biotech Penny Stock Is Better Than Dogecoin
You might want to avoid buying it, though.
Why Corbus Pharmaceuticals Is Getting Slammed Today
A late-stage clinical failure is weighing heavily on the biotech's stock today.
2 Dirt-Cheap Robinhood Stocks That Could Skyrocket
These cheap companies have upcoming binary catalysts for explosive growth.
3 Awful Stocks Robinhood Investors Love -- and 1 of the Best
Pharmaceutical stocks are popular with Robinhood Investors, including three I would stay away from and one that I wouldn't.
Robinhood Investors Love These 3 Biotech Stocks. Should You?
Could the most popular biotech stocks on Robinhood be the biggest winners for other investors?
3 Stocks Robinhood Investors Love
These have the highest analyst ratings among Robinhood's 100 most popular stocks.
3 Big Pharma Stocks With Surprising Cannabis Connections
These pharmaceutical giants are already preparing for the possibility of medical marijuana legalization.
3 Biotech Stocks Robinhood Investors Love, and 1 They Should
Two biotechs have big risks, one is a buy, and the other is a big opportunity to consider.
Valuation
Earnings Transcripts
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Q4 2020 Earnings Call Transcript
CRBP earnings call for the period ending December 31, 2020.
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Q3 2020 Earnings Call Transcript
CRBP earnings call for the period ending September 30, 2020.
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Q2 2020 Earnings Call Transcript
CRBP earnings call for the period ending June 30, 2020.
Corbus Pharmaceuticals Holdings, Inc. (CRBP) Q1 2020 Earnings Call Transcript
CRBP earnings call for the period ending March 31, 2020.
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.